CA2328062A1 - Proteines secretees et polynucleotides codant pour ces dernieres - Google Patents

Proteines secretees et polynucleotides codant pour ces dernieres Download PDF

Info

Publication number
CA2328062A1
CA2328062A1 CA002328062A CA2328062A CA2328062A1 CA 2328062 A1 CA2328062 A1 CA 2328062A1 CA 002328062 A CA002328062 A CA 002328062A CA 2328062 A CA2328062 A CA 2328062A CA 2328062 A1 CA2328062 A1 CA 2328062A1
Authority
CA
Canada
Prior art keywords
seq
nucleotide sequence
nucleotide
amino acid
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002328062A
Other languages
English (en)
Inventor
Gordon G. Wong
Hilary F. Clark
Kim Fechtel
Michael J. Agostino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/311,021 external-priority patent/US6706869B1/en
Application filed by Individual filed Critical Individual
Publication of CA2328062A1 publication Critical patent/CA2328062A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)

Abstract

La présente invention concerne de nouveaux polynucléotides et les protéines pour lesquelles ils codent.
CA002328062A 1998-05-14 1999-05-14 Proteines secretees et polynucleotides codant pour ces dernieres Abandoned CA2328062A1 (fr)

Applications Claiming Priority (27)

Application Number Priority Date Filing Date Title
US8547298P 1998-05-14 1998-05-14
US60/085,472 1998-05-14
US9682498P 1998-08-17 1998-08-17
US60/096,824 1998-08-17
US9984398P 1998-09-11 1998-09-11
US9995098P 1998-09-11 1998-09-11
US60/099,843 1998-09-11
US60/099,950 1998-09-11
US10042498P 1998-09-15 1998-09-15
US60/100,424 1998-09-15
US10232998P 1998-09-29 1998-09-29
US60/102,329 1998-09-29
US10361598P 1998-10-09 1998-10-09
US60/103,615 1998-10-09
US11179998P 1998-12-11 1998-12-11
US60/111,799 1998-12-11
US11215998P 1998-12-14 1998-12-14
US60/112,159 1998-12-14
US11441598P 1998-12-31 1998-12-31
US60/114,415 1998-12-31
US24805999A 1999-02-10 1999-02-10
US09/248,059 1999-02-10
US28715099A 1999-04-06 1999-04-06
US09/287,150 1999-04-06
US09/311,021 US6706869B1 (en) 1998-02-11 1999-05-13 Map kinase phosphatases and polynucleotides encoding them
US09/311,021 1999-05-13
PCT/US1999/010843 WO1999058642A2 (fr) 1998-05-14 1999-05-14 Proteines secretees et polynucleotides codant pour ces dernieres

Publications (1)

Publication Number Publication Date
CA2328062A1 true CA2328062A1 (fr) 1999-11-18

Family

ID=27584491

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002328062A Abandoned CA2328062A1 (fr) 1998-05-14 1999-05-14 Proteines secretees et polynucleotides codant pour ces dernieres

Country Status (4)

Country Link
EP (1) EP1080180A2 (fr)
JP (1) JP2003530296A (fr)
CA (1) CA2328062A1 (fr)
WO (1) WO1999058642A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083700A (en) 1998-06-26 2000-07-04 Incyte Pharmaceuticals, Inc. Human goose-type lysozyme
DE69925008D1 (de) * 1998-10-09 2005-06-02 Med College Georgia Res Inst Protein, welches die aktivität von d1-ähnlichen dopamin rezeptoren modifiziert
US6960433B1 (en) 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
WO2000053636A2 (fr) * 1999-03-08 2000-09-14 Ceptyr, Inc. Phosphatase dsp-1 a double specificite
WO2000060078A2 (fr) * 1999-04-01 2000-10-12 Cold Spring Harbor Laboratory Latheo codant une sous-unite de proteines complexes de reconnaissance d'origine
DE60043242D1 (de) * 1999-08-03 2009-12-10 Genentech Inc Ausgeschiedene und transmembrane Polypeptide und dafür kodierende Nukleinsäure
WO2001014552A1 (fr) * 1999-08-19 2001-03-01 Kurokawa, Kiyoshi Proteine meg-1
WO2001042291A2 (fr) * 1999-12-10 2001-06-14 Curagen Corporation Nouveaux polypeptides et polynucleotides codant pour ces polypeptides
CA2399569A1 (fr) * 2001-09-25 2003-03-25 Yusuke Nakamura Marqueurs diagnostiques et cibles therapeutiques pour le traitement du cancer
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
SG194099A1 (en) 2011-04-15 2013-11-29 Compugen Ltd Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer

Also Published As

Publication number Publication date
WO1999058642A3 (fr) 2000-03-02
EP1080180A2 (fr) 2001-03-07
WO1999058642A2 (fr) 1999-11-18
JP2003530296A (ja) 2003-10-14

Similar Documents

Publication Publication Date Title
US6380362B1 (en) Polynucleotides, polypeptides expressed by the polynucleotides and methods for their use
CA2339047A1 (fr) Proteines secretees et polynucleotides les codant
Sprecher et al. Cloning and characterization of a novel class I cytokine receptor
Oda et al. Identification and Cloning of the Human Homolog (JAG1) of the RatJagged1Gene from the Alagille Syndrome Critical Region at 20p12
US20030092175A1 (en) Human proteins having transmembrane domains and dnas encoding these proteins
CA2226087A1 (fr) Sequences nucleotidiques et proteiques de genes delta de vertebres et procedes fondes sur ces dernieres
CA2328062A1 (fr) Proteines secretees et polynucleotides codant pour ces dernieres
CA2338186A1 (fr) Facteur de necrose tumorale gamma
CA2327457A1 (fr) Proteines secretees et polynucleotides codant pour celles-ci
US6242419B1 (en) Compositions isolated from stromal cells and methods for their use
US20010039335A1 (en) Secreted proteins and polynucleotides encoding them
WO1998055614A2 (fr) Proteines secretees et polynucleotides codant ces proteines
WO1999054447A2 (fr) Sequences d'acide nucleique provenant de tissus tumoraux de la vessie
CA2382622A1 (fr) Molecules induites par un hydrocarbure aromatique polycyclique
AU784881B2 (en) Human transporter proteins and polynucleotides encoding the same
EP1012286B1 (fr) Gene allelomorphe du stat3 humain
US6590089B1 (en) RVP-1 variant differentially expressed in Crohn's disease
CA2378485A1 (fr) Facteur de differenciation de proliferation
US6960649B2 (en) Human potassium channel polynucleotides and polypeptides and uses thereof
Kim et al. Cloning of novel trinucleotide-repeat (CAG) containing genes in mouse brain
EP1297011B1 (fr) Utilisation diagnostique de la nouvelle proteine de cellules-t (tzon7), des peptides et des anticorps derives de ceux-ci
EP1939292A2 (fr) Acides nucléiques isolés dans le neuroblaste
US20070037161A1 (en) Motoneuronotrophic factor gene sequences
US20010010926A1 (en) New immunoregulatory protein lst-1
JPH06315382A (ja) Ｔｉｅ−２受容体をコードするｄｎａ及びｔｉｅ−２受容体

Legal Events

Date Code Title Description
FZDE Dead